| YHL037C |
Saccharomyces cerevisiae |
|
YHL037C is differentially expressed in 14 experiments [15 up/13 dn]: 3 compound treatments: doxycycline [1 up/0 dn], none [0 up/1 dn], ...; 2 developmental stages: mitotic growth [1 up/0 dn], meiotic development [0 up/1 dn], 11 genotypes, 4 growth conditions, 1 material types and 1 other conditions. |
| YHL037C |
|
|
|
P38733
|
|
|
|
YHL037C
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Wild_type
|
Genotype |
|
|
Doxycycline
|
Compound treatment |
|
|
None
|
Compound treatment |
|
|
Nmd2::HIS3 xrn1::ADE2
|
Genotype |
|
|
Mitotic growth
|
Developmental stage |
|
|
Meiotic development
|
Developmental stage |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
H2B 30-37 deletion
|
Genotype |
|
|
Abf1-1 hypomorph, homozygous
|
Genotype |
|
|
H3(K4,9,14,18,23,27Q)
|
Genotype |
|
|
YPD media
|
Growth condition |
|
|
Upf1Δ
|
Genotype |
|
|
SPII media
|
Growth condition |
|
|
Monosomal_RNA
|
Material type |
|
|
H2B K to G substitution
|
Genotype |
|
|
H2B 3-37 deletion
|
Genotype |
|
|
CY2-4C
|
Strain or line |
|
|
NSY438
|
Strain or line |
|
|
Dessication
|
Growth condition |
|
|
Control
|
Growth condition |
|
|
Rpd3Δ H3delta(1-28)
|
Genotype |
|
|
Sodium chloride
|
Compound treatment |
|
|
H4 Δ2-26
|
Genotype |
|
|
|
|
|
Processing time: 0.028 secs.